Identification and Characterization of CD133CD44 Cancer Stem Cells from Human Laryngeal Squamous Cell Carcinoma Cell Lines

Overview

Journal J Cancer

Specialty Oncology

Date 2017 Mar 7

PMID 28261352

Citations 32

Authors

Jue Wang

Yongyan Wu

Wei Gao

Fei Li

Yunfeng Bo

Meixia Zhu

Rong Fu

Qingqing Liu

Shuxin Wen

Binquan Wang

Affiliations

Soon will be listed here.

Abstract

Laryngeal squamous cell carcinoma ranks second among head and neck squamous-cell carcinomas. Cancer stem cells can support cancer growth and malignant behavior. Therefore, cancer stem cells isolated from laryngeal squamous cell carcinoma tissue could be used to investigate the initiation, progression, and treatment strategies of this cancer. We isolated CD133-CD44-, CD133-CD44+, CD133+CD44- and CD133+CD44+ cell populations from laryngeal squamous-cell carcinoma cell lines Hep2 and TU-177 by magnetic-activated cell sorting. Sphere formation, cell proliferation, migration, invasion, colony formation, resistance to radio- and chemotherapy, and in vivo tumorigenicity of these populations were evaluated. Moreover, we investigated the expression of the stem-cell markers (sex determining region Y)-box 2 (SOX2) and octamer-binding transcription factor 4 (OCT4) in CD133-CD44-, CD133-CD44+, CD133+CD44-, CD133+CD44+ cell populations and parental Hep2 and TU-177 cells. As compared with CD133-CD44-, CD133-CD44+, CD133+CD44- populations and parental cells, CD133+CD44+ cells showed higher cell viability, migration and invasive capability and colony formation ability as well as stronger resistance to cisplatin and irradiation. Moreover, levels of SOX2 and OCT4 and tumorigenicity in nude mice were greater in CD133+CD44+ Hep2 and TU-177 cells than other cell populations and parental cells. The CD133+CD44+ population of laryngeal squamous-cell carcinoma Hep2 and TU-177 cells have stem cell properties and showed more malignant features than CD133+CD44- and CD133-CD44+ cell populations. CD133+CD44+ cancer stem cells may be a promising target for developing anticancer drugs and treatment strategies for laryngeal squamous cell carcinoma.

Citing Articles

Characterization of Cancer Stem Cells in Laryngeal Squamous Cell Carcinoma by Single-cell RNA Sequencing.

Li Y, Lin C, Chu Y, Wei Z, Ding Q, Gu S Genomics Proteomics Bioinformatics. 2024; 22(4).

PMID: 39107908 PMC: 11522873. DOI: 10.1093/gpbjnl/qzae056.

Red light-activated depletion of drug-refractory glioblastoma stem cells and chemosensitization of an acquired-resistant mesenchymal phenotype.

Spring B, Watanabe K, Ichikawa M, Mallidi S, Matsudaira T, Timerman D Photochem Photobiol. 2024; 101(1):215-229.

PMID: 38922889 PMC: 11664018. DOI: 10.1111/php.13985.

Cancer Stem Cells from Definition to Detection and Targeted Drugs.

Ruszkowska-Ciastek B, Kwiatkowska K, Marques-da-Silva D, Lagoa R Int J Mol Sci. 2024; 25(7).

PMID: 38612718 PMC: 11011379. DOI: 10.3390/ijms25073903.

The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma.

Cierpikowski P, Leszczyszyn A, Bar J Cells. 2023; 12(16).

PMID: 37626893 PMC: 10453169. DOI: 10.3390/cells12162083.

Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells.

Spada M, Piras C, Diana G, Leoni V, Frau D, Serreli G Antioxidants (Basel). 2023; 12(3).

PMID: 36978930 PMC: 10045305. DOI: 10.3390/antiox12030683.

References

Yu L, Zhou L, Wu S, Gong X, Feng Z, Ma L . Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma. World J Surg Oncol. 2014; 12:118. PMC: 4012248. DOI: 10.1186/1477-7819-12-118. View

Horst D, Scheel S, Liebmann S, Neumann J, Maatz S, Kirchner T . The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol. 2009; 219(4):427-34. DOI: 10.1002/path.2597. View

Wu C, Zhou L, Xie M, Du H, Tian J, Sun S . Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia. PLoS One. 2013; 8(6):e65750. PMC: 3679141. DOI: 10.1371/journal.pone.0065750. View

Zhong C, Wu J, Fang M, Pu L . Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis. Tumour Biol. 2015; 36(10):7623-30. DOI: 10.1007/s13277-015-3487-y. View

Chen J, Zhou J, Lu J, Xiong H, Shi X, Gong L . Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis. BMC Cancer. 2014; 14:15. PMC: 3893437. DOI: 10.1186/1471-2407-14-15. View

Chu E, Kim Y . Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008; 41(4):673-95, v. DOI: 10.1016/j.otc.2008.01.016. View

Xia P . Surface markers of cancer stem cells in solid tumors. Curr Stem Cell Res Ther. 2013; 9(2):102-11. DOI: 10.2174/1574888x09666131217003709. View

Vincent Z, Urakami K, Maruyama K, Yamaguchi K, Kusuhara M . CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile. Genes Cancer. 2014; 5(7-8):250-60. PMC: 4162140. DOI: 10.18632/genesandcancer.23. View

Geens M, van de Velde H, De Block G, Goossens E, VAN Steirteghem A, Tournaye H . The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients. Hum Reprod. 2006; 22(3):733-42. DOI: 10.1093/humrep/del418. View

10.

Bi Y, Meng Y, Wu H, Cui Q, Luo Y, Xue X . Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. J Surg Oncol. 2016; 113(2):144-51. DOI: 10.1002/jso.24124. View

11.

Gourin C, Dy S, Herbert R, Blackford A, Quon H, Forastiere A . Treatment, survival, and costs of laryngeal cancer care in the elderly. Laryngoscope. 2014; 124(8):1827-35. DOI: 10.1002/lary.24574. View

12.

Noto Z, Yoshida T, Okabe M, Koike C, Fathy M, Tsuno H . CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics. Oral Oncol. 2013; 49(8):787-95. DOI: 10.1016/j.oraloncology.2013.04.012. View

13.

Sahlberg S, Spiegelberg D, Glimelius B, Stenerlow B, Nestor M . Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS One. 2014; 9(4):e94621. PMC: 3997403. DOI: 10.1371/journal.pone.0094621. View

14.

Huang C, Zhu Y, Duan G, Yao J, Li Z, Li D . Screening for MiRNAs related to laryngeal squamous carcinoma stem cell radiation. Asian Pac J Cancer Prev. 2013; 14(8):4533-7. DOI: 10.7314/apjcp.2013.14.8.4533. View

15.

Prince M, Sivanandan R, Kaczorowski A, Wolf G, Kaplan M, Dalerba P . Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007; 104(3):973-8. PMC: 1783424. DOI: 10.1073/pnas.0610117104. View

16.

Suer I, Karatas O, Yuceturk B, Yilmaz M, Guven G, Buge O . Characterization of stem-like cells directly isolated from freshly resected laryngeal squamous cell carcinoma specimens. Curr Stem Cell Res Ther. 2014; 9(4):347-53. DOI: 10.2174/1574888x09666140330201632. View

17.

Di Mitri D, Toso A, Chen J, Sarti M, Pinton S, Rezzonico Jost T . Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature. 2014; 515(7525):134-7. DOI: 10.1038/nature13638. View

18.

Valli H, Sukhwani M, Dovey S, Peters K, Donohue J, Castro C . Fluorescence- and magnetic-activated cell sorting strategies to isolate and enrich human spermatogonial stem cells. Fertil Steril. 2014; 102(2):566-580.e7. PMC: 4128386. DOI: 10.1016/j.fertnstert.2014.04.036. View

19.

Karatas O, Suer I, Yuceturk B, Yilmaz M, Hajiyev Y, Creighton C . The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells. Tumour Biol. 2015; 37(3):4183-92. DOI: 10.1007/s13277-015-4219-z. View

20.

Wang L, Guo H, Lin C, Yang L, Wang X . Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line. Mol Med Rep. 2014; 9(6):2117-23. PMC: 4055449. DOI: 10.3892/mmr.2014.2063. View